RAIN THERAPEUTICS INC's ticker is RAIN and the CUSIP is 75082Q105. A total of 59 filers reported holding RAIN THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $2,441,462 | +39.2% | 2,034,552 | 0.0% | 0.38% | -29.2% |
| Q3 2023 | $1,753,377 | -28.2% | 2,034,552 | 0.0% | 0.54% | +25.2% |
| Q2 2023 | $2,441,462 | -87.6% | 2,034,552 | -10.0% | 0.43% | -89.5% |
| Q1 2023 | $19,758,098 | +9.2% | 2,260,652 | 0.0% | 4.08% | +4.9% |
| Q4 2022 | $18,085,216 | +137.5% | 2,260,652 | +44.9% | 3.89% | +119.1% |
| Q3 2022 | $7,616,000 | -12.2% | 1,560,652 | 0.0% | 1.78% | -23.2% |
| Q2 2022 | $8,677,000 | +8.9% | 1,560,652 | -0.7% | 2.31% | +15.3% |
| Q1 2022 | $7,967,000 | -60.6% | 1,571,379 | 0.0% | 2.01% | -48.9% |
| Q4 2021 | $20,239,000 | -13.9% | 1,571,379 | 0.0% | 3.93% | +6.5% |
| Q3 2021 | $23,508,000 | -7.6% | 1,571,379 | -4.0% | 3.69% | +17.4% |
| Q2 2021 | $25,444,000 | – | 1,637,308 | – | 3.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 2,260,652 | $19,758,098 | 4.08% |
| Cormorant Asset Management, LP | 2,978,660 | $26,033 | 1.71% |
| BVF INC/IL | 3,526,729 | $30,823,611 | 1.13% |
| Boxer Capital, LLC | 2,147,212 | $18,767 | 0.92% |
| SECTORAL ASSET MANAGEMENT INC | 484,928 | $4,238,271 | 0.82% |
| Ghost Tree Capital, LLC | 250,000 | $2,185,000 | 0.65% |
| Perceptive Advisors | 1,648,215 | $14,405,399 | 0.42% |
| GMT CAPITAL CORP | 824,865 | $7,209,320 | 0.28% |
| Monashee Investment Management LLC | 31,159 | $272,330 | 0.08% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 227,393 | $1,987,415 | 0.04% |